Articles by author - Andrzej Kedzia

Evaluation of final height prediction and selected parameters in Polish patients with severe and partial growth hormone deficiency.

Biczysko-Mokosa A, Petriczko E, Horodnicka-Józwa A, Dawid G, Kedzia A, Lewiński A, Walczak M.

Comparative Study 2014; 35(3): 242-247 PubMed PMID: 24977976  Keywords:  Adolescent, Body Height, Child, Dwarfism, Pituitary:drug therapy, Female, Hormone Replacement Therapy, Human Growth Hormone:therapeutic use, Humans, Male, Poland, Prognosis, Recombinant Proteins:therapeutic use, Severity of Illness Index,.    Citation

OBJECTIVES: The main goal of growth hormone therapy is to reach the height in the population ranges. The aim of the study was the comparis.....

Read abstract  Full text PDF

Unfavorable effects of hyperprolactinemia in autoimmune endocrine disorders.

Krysiak R, Kędzia A, Okopień B.

Case Reports 2012; 33(3): 298-300 PubMed PMID: 22635088  Keywords:  Aminoquinolines:administration & dosage, Disease Progression, Dopamine Agonists:administration & dosage, Female, Humans, Hyperprolactinemia:complications, Prolactin:blood, Thyroiditis, Autoimmune:complications, Young Adult, Zona Glomerulosa:immunology,.    Citation

: Prolactin is a hormone with a multidirectional proinflammatory action. It has an anti-apoptotic effect, enhances proliferative response .....

Read abstract  Full text PDF